Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control (2024)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2024.01.010

Publication URI: http://dx.doi.org/10.1016/j.jcyt.2024.01.010

Type: Journal Article/Review

Parent Publication: Cytotherapy